Insiders · AZR

AZR insider transactions

Azora Therapeutics Inc. (AZR) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

AZR insiders

Everyone who has filed a Form 4 or 5 at Azora Therapeutics Inc., latest first. Follow anyone to get their next filing.

• Matt DavidsonPresident and CEO, Director
• Julie SaikiChief Strategy Officer
• Coastlands Capital LP10% owner+$106K
• Wendy B. YoungDirector
• J. Kermit AndersonDirector
• Tony GoodmanChief Operating Officer, Director
• Vinay ShahChief Financial Officer
• Kevin SchuylerDirector, 10% owner+$1,918
• Cary J ClaiborneChief Executive Officer, Director
• Robertson H. GillilandDirector
• James W. Newman Jr.Director+$95.8K
• Joseph TruluckChief Financial Officer
• Bankole A. JohnsonOfficer, Director-$375K
• William B. Stilley IIIOfficer, Director, 10% owner+$55.1K

Recent Form 3, 4, and 5 filings for AZR

• 2d
  President and CEO Davidson Matt converted options into 626,252 shares, increasing direct ownership by 179% to 819,018 units (SEC Form 4)

  4 - Azora Therapeutics, Inc. (DE) (0001513525) (Issuer)
• 2d
  Chief Strategy Officer Saiki Julie converted options into 626,252 shares, increasing direct ownership by 463% to 761,636 units (SEC Form 4)

  4 - Azora Therapeutics, Inc. (DE) (0001513525) (Issuer)
• 3d
  SEC Form 4 filed by Large owner Coastlands Capital Lp

  4 - Azora Therapeutics, Inc. (DE) (0001513525) (Issuer)